James P. Zallie, President and CEO of Ingredion (INGR +0.02%), reported the open-market sale of 33,597 shares for a total of approximately $4.02 million on Feb. 11, 2026, according to a SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 33,597 |
| Transaction value | ~$4.02 million |
| Post-transaction shares (direct) | 50,166 |
| Post-transaction value (direct ownership) | ~$6.01 million |
Transaction value based on SEC Form 4 weighted average purchase price ($119.66); post-transaction value based on Feb. 11, 2026 market close ($119.66).
Key questions
- What proportion of Zallie's direct ownership does this transaction represent?
The sale accounted for 40.11% of his direct ownership at the time, a larger percentage than recent historical medians, which is explained by the reduction in available shares post prior dispositions. - Was this transaction linked to any derivative securities or option exercises?
No derivative securities or option exercises were involved; the entire disposition consisted of directly held common shares sold in the open market.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $7.22 billion |
| Net income (TTM) | $729.00 million |
| Dividend yield | 2.98% |
| 1-year price change | -4.23% |
* 1-year price change calculated using Feb. 11, 2026 as the reference date.
NYSE: INGR
Key Data Points
Company snapshot
Ingredion is a global ingredient solutions provider that produces and sells starches, sweeteners, corn oil, protein feeds, and specialty food ingredients derived from corn and other starch-based materials. It serves food and beverage manufacturers, animal nutrition producers, and industrial clients globally across North America, South America, Asia-Pacific, and EMEA regions.
What this transaction means for investors
In addition to serving as President and CEO, Zallie was appointed Chairman of the Board of Ingredion on Feb. 11, 2026. He was unanimously elected as Chair after former Chair Gregory Kenny announced his decision to step down.
This move and Zallie’s sale of shares shouldn’t be of concern to investors. Board member reshuffling is common amongst businesses, and Zallie’s transaction was part of a Rule 10b5-1 trading plan, where insiders can plan a purchase or sale of shares ahead of time.
What may be of concern to investors though is that the company had a rather lackluster Q4 earnings report for its fiscal year 2025.
While net income and earnings per share (EPS) grew year-over-year, revenue declined during that period. In addition, the company posted its third consecutive quarter of decline in net income and EPS after starting the fiscal year strongly. The company is still recovering from global impacts on its production, so that is something investors may want to monitor.
